Patient Guide: HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 31 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04676477
Status: ACTIVE_NOT_RECRUITING
Condition: Non-Small Cell Lung Cancer (NSCLC)
Phase: PHASE1

Find a Study Location Near You

This study is available at 31 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Santa Monica, California
  • New Haven, Connecticut
  • Washington, District of Columbia
  • • And 28 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily